Medtech Developments - PRWeb Press Release Group http://www.rsspad.com/rss2/13161.xml Developments in medical technology (devices, biomaterials, biotech, others) including product innovations, market developments and others. - Powered by PRWeb and RSSPad en xml@emediawire.com xml@emediawire.com 30 http://www.prweb.com/userfiles/200611/MMD_logo_113w_50h.jpg Happy Image http://www.prweb.com/ Coronary Stents Market Worldwide Holds Big Incentive for Growth, Opportunity in Novel Technologies, According to MedMarket Diligence Report http://www.prweb.com/releases/2009/05/prweb2387394.htm The market for coronary stents worldwide is well established, large and still demonstrating excellent growth, especially with the advent of new technologies from established and hopeful competitors. While drug-eluting stents (DES), having survived the "late stage thrombosis" setback, represent the strongest current market growth, novel stent technologies (bioabsorbable and others) are soon to emerge to at least momentarily eclipse DES market growth. The worldwide coronary stent market is analyzed in a new report from MedMarket Diligence, LLC. (PRWeb May 6, 2009)

Read the full story at http://www.prweb.com/releases/2009/05/prweb2387394.htm

]]> Wed, 06 May 2009 07:00:00 GMThttp://www.prweb.com/releases/2009/05/prweb2387394.htm Ablation Technologies and Other Energy-Based Therapies Proliferating in Cardiology, General Surgery, Cancer and Other Clinical Applications Worldwide http://www.prweb.com/releases/2008/09/prweb1316844.htm The global market for ablation and other energy-based therapeutics is swelling at double digit growth rates, with revenues in some energy types growing at or beyond 20% annually. The efficacy of different modalities in achieving different clinical end-points (cutting, coagulating, excising tissue, creating anti-arrhythmic lesions, etc.) is increasing with new product developments and products are being more readily adopted by clinicians becoming facile with their use. The worldwide market for ablation and other energy-based technologies is the subject of a new market and technology report, "Worldwide Ablation Technologies", from MedMarket Diligence, LLC (PRWeb Sep 12, 2008)

Read the full story at http://www.prweb.com/releases/2008/09/prweb1316844.htm

]]> Fri, 12 Sep 2008 07:00:00 GMThttp://www.prweb.com/releases/2008/09/prweb1316844.htm Worldwide Spine Surgery Market Characterized by Many New Technologies, Dynamics and Double Digit Growth, According to New Report from MedMarket Diligence, LLC http://www.prweb.com/releases/2008/03/prweb768714.htm Among the most device-intensive healthcare markets, the spine surgery market has been undergoing dramatic changes as numerous new technologies take hold in the well established spine surgery surgical arena and manufacturers continue to develop new technologies and roll them out for a growing patient population. Globally, the market will grow to over $26 billion over the next ten years, demonstrating double digit growth in the process. A new report from MedMarket Diligence details the products, technologies, markets and companies worldwide. (PRWeb Mar 14, 2008)

Read the full story at http://www.prweb.com/releases/2008/03/prweb768714.htm

]]> Fri, 14 Mar 2008 07:00:00 GMThttp://www.prweb.com/releases/2008/03/prweb768714.htm Wound Management Market Worldwide 2007-2016: Products, Technologies and Established/Growth Market Opportunities in New Report from MedMarket Diligence, LLC http://www.prweb.com/releases/2007/11/prweb569276.htm Products in wound management span simple dressings and bandages to advanced biotech, mechanical and other technologies designed to facilitate and accelerate the wound healing process. The combined nature of the resulting product market -- from well established high volume sectors to rapid growth emerging sectors -- represents enormous business potential for current and prospective wound management companies. (PRWeb Nov 14, 2007)

Read the full story at http://www.prweb.com/releases/2007/11/prweb569276.htm

]]> Wed, 14 Nov 2007 08:00:00 GMThttp://www.prweb.com/releases/2007/11/prweb569276.htm Bone Grafts/Substitutes, Polymers, Ceramics, Growth Factors and Tissue Engineering in Orthopedics http://www.prweb.com/releases/2007/04/prweb521419.htm The use of products collectively known as "orthopedic biomaterials" represents a growing share of clinical practice in orthopedics. Current uses, products on the market, new products under development and their sales in the worldwide market are detailed in a MedMarket Diligence report that reveals opportunities for competitors. (PRWeb Apr 26, 2007)

Read the full story at http://www.prweb.com/releases/2007/04/prweb521419.htm

]]> Thu, 26 Apr 2007 07:00:00 GMThttp://www.prweb.com/releases/2007/04/prweb521419.htm Surgical Sealants, Glues and Wound Closure Worldwide Markets, Growth and Opportunities, 2006-2011 (from MMD, LLC) http://www.prweb.com/releases/2007/02/prweb504432.htm MedMarket Diligence has tracked the emergence and growth of novel technologies in wound closure, hemostasis and anti-adhesion over the past decade, providing insight into market introduction, growth, competition and opportunity through worldwide analysis. The products, markets and companies in this medical technology arena have now been analyzed in a new report from MedMarket Diligence. The 2007 report details the markets worldwide, with detailed geographic segmentation, for surgical sealants, glues, hemostats, sutures, tapes and other wound closure technologies. (PRWeb Feb 13, 2007)

Read the full story at http://www.prweb.com/releases/2007/02/prweb504432.htm

]]> Tue, 13 Feb 2007 08:00:00 GMThttp://www.prweb.com/releases/2007/02/prweb504432.htm Ophthalmology Devices, Drugs, and Diagnostics Market Report with Country-Specific Forecasts, Segment-Specific Market Share Forecasts to 2012 from MMD, LLC http://www.prweb.com/releases/2007/01/prweb495977.htm One of the most detailed market reports from MedMarket Diligence (MMD), this report presents the current state of the ophthalmic diagnostic, drug and device markets and reveals the trends and opportunites in ophthalmology products by segment, country and competitor worldwide. Drawn from insider expertise, and completed through extensive research of primary and secondary sources, the report is an invaluable resource to understand current and evolving markets for ophthalmology products. (PRWeb Jan 10, 2007)

Read the full story at http://www.prweb.com/releases/2007/01/prweb495977.htm

]]> Wed, 10 Jan 2007 08:00:00 GMThttp://www.prweb.com/releases/2007/01/prweb495977.htm Worldwide Market for Orthopedic Biomaterials (Report): Products, Markets, Shares and Outlook Globally (from MedMarket Diligence) http://www.prweb.com/releases/2006/12/prweb487254.htm The orthopedic biomaterials market is an evolving arena in the development, adoption and/or evolving use of bone, bone substitutes, polymers, ceramics, bone growth factors, sealants/glues, anti-adhesion, tissue engineering and other products. The market is party to established orthopedic device manufacturers as well as niche biomaterials companies with innovative offerings. The resulting $5 billion current orthopedic biomaterials market will grow at double digit annual rates reaching nearly $10 billion by 2011. MedMarket Diligence has completed a global report on products, technologies, markets and players, with insights on the market's outlook. (PRWeb Dec 5, 2006)

Read the full story at http://www.prweb.com/releases/2006/12/prweb487254.htm

]]> Tue, 05 Dec 2006 08:00:00 GMThttp://www.prweb.com/releases/2006/12/prweb487254.htm The $22 Billion Worldwide Market for Ophthalmic Devices, Drugs and Diagnostics, 2007; a Report from MedMarket Diligence, LLC http://www.prweb.com/releases/2006/11/prweb477741.htm MedMarket Diligence has completed a comprehensive worldwide analysis of the market for drugs, devices and diagnostics in ophthalmology. The analysis spans detailed segment coverage per country globally, with detailed incidence/prevalence data (by country/region), market size/growth (by country region) and product, technology and company data (including forecast share data per country/region) for vision correction and eye disorders/conditions. (PRWeb Nov 14, 2006)

Read the full story at http://www.prweb.com/releases/2006/11/prweb477741.htm

]]> Tue, 14 Nov 2006 08:00:00 GMThttp://www.prweb.com/releases/2006/11/prweb477741.htm Nanotech and MEMS in Medical Applications: Comprehensive Market and Technology Report Released from MedMarket Diligence http://www.prweb.com/releases/2006/05/prweb391580.htm The most extraordinary possibilities of nanotechnology and MEMS (microelectromechanical systems) remain to be developed, yet a $billion+ market already exists for these technologies in biomedical applications, spanning cancer treatment, drug delivery, wound management, sensor technologies, pacemakers, molecular diagnostics, hearing aids and others. The current markets, the current status of development and the emerging and potential markets worldwide are detailed in a new report from MedMarket Diligence. (PRWeb May 30, 2006)

Read the full story at http://www.prweb.com/releases/2006/05/prweb391580.htm

]]> Tue, 30 May 2006 07:00:00 GMThttp://www.prweb.com/releases/2006/05/prweb391580.htm High Growth Medical Technologies -- Insights from Tracking Market Opportunities; A White Paper from MMD (MedMarket Diligence) http://www.prweb.com/releases/2006/05/prweb382882.htm By tracking the medical device marketplace and its expanding sphere of competing and complementary technologies, MedMarket Diligence has identified a range of diverse technologies and technology disciplines with high current and/or potential growth in the market, and has identified underlying forces behind the growth. (PRWeb May 10, 2006)

Read the full story at http://www.prweb.com/releases/2006/05/prweb382882.htm

]]> Wed, 10 May 2006 07:00:00 GMThttp://www.prweb.com/releases/2006/05/prweb382882.htm Global Analysis of Diabetes Products, Technologies and Markets Reveals Many Opportunities for Device, Drug and Diagnostics Manufacturers (Report by MedMarket Diligence) http://www.prweb.com/releases/2005/12/prweb322112.htm MedMarket Diligence, a highly regarded source of data and insight in medtech markets, has analyzed the $25 billion market for drugs/medications, devices, diagnostics, therapeutics and their combinations in the management of diabetes, with data and insights provided on worldwide and geographic segmentation. The analysis reveals high growth opportunities for manufacturers. (PRWeb Dec 15, 2005)

Read the full story at http://www.prweb.com/releases/2005/12/prweb322112.htm

]]> Thu, 15 Dec 2005 08:00:00 GMThttp://www.prweb.com/releases/2005/12/prweb322112.htm Computer-Aided Surgery, Imaging Markets Focus of New Report from MedMarket Diligence, LLC http://www.prweb.com/releases/2005/10/prweb302045.htm The global computer-aided surgery market is approximately $465 million and growing rapidly. In the U.S., the computer-aided surgery market was an estimated $296M in 2004. As new companies enter this arena, the annual growth rate is expected to increase from its current level of approximately 10% in 2005 to more than 20% in 2009, according to a new report from MedMarket Diligence. (PRWeb Oct 26, 2005)

Read the full story at http://www.prweb.com/releases/2005/10/prweb302045.htm

]]> Wed, 26 Oct 2005 07:00:00 GMThttp://www.prweb.com/releases/2005/10/prweb302045.htm Wound Management Market Segments Growing at Rates of Up to 17% Annually in Key Product and Regional Market Areas, According to New Report from MedMarket Diligence, LLC http://www.prweb.com/releases/2005/08/prweb270143.htm Globally, the market for the diverse array of products in surgical, chronic and acute wound management stands at $13 billion, with aggregate growth at 7% annually. Select product and geographic sectors are demonstrating appreciably stronger growth. The global market for wound management is analyzed in a new MedMarket Diligence report. (PRWeb Aug 8, 2005)

Read the full story at http://www.prweb.com/releases/2005/08/prweb270143.htm

]]> Mon, 08 Aug 2005 07:00:00 GMThttp://www.prweb.com/releases/2005/08/prweb270143.htm Tissue Engineering and Cell Therapy Showing Proof-of-Concept, Encouraging Continued Investment and Acquisition, According to New Report from MedMarket Diligence, LLC http://www.prweb.com/releases/2005/04/prweb229571.htm The technologies that have been under development for the engineering of tissues and cell-based therapies for over 25 years continue to face challenges in achieving specific, marketable applications more complex than engineered skin grafts, cartilage and bone. And, despite frequent advances and achievements in the laboratory and the infusion of huge amounts of capital, the bigger challenge for many companies dedicated to tissue engineering and cell therapy is to simply stay in business long enough to commercialize their products. Notwithstanding all of these challenges, many technologies are demonstrating proof-of-concept to the degree that they have engendered the continued financial support of the investment industry, the device industry, the pharmaceutical industry and others who remain convinced that the potential rewards of the long R&D process are within a manageable timeline, according to newly completed report by MedMarket Diligence. (PRWeb Apr 16, 2005)

Read the full story at http://www.prweb.com/releases/2005/04/prweb229571.htm

]]> Sat, 16 Apr 2005 07:00:00 GMThttp://www.prweb.com/releases/2005/04/prweb229571.htm Spine Surgery Technologies, Products Generating Clinical Success, Driving and Sustaining Large Markets, According to a March 2005 Analysis Report by MedMarket Diligence http://www.prweb.com/releases/2005/03/prweb216981.htm The worldwide market for products in spine surgery is poised for strong and sustainable growth through the coming decades as a range of new products, from artificial discs to use of minimally invasive techniques and wealth of osteobiologics find their way into a growing medical practice comprised of an active baby boomer population. The worldwide markets for these technologies, and the opportunities emerging, are detailed in a newly published report by MedMarket Diligence. (PRWeb Mar 10, 2005)

Read the full story at http://www.prweb.com/releases/2005/03/prweb216981.htm

]]> Thu, 10 Mar 2005 08:00:00 GMThttp://www.prweb.com/releases/2005/03/prweb216981.htm